There were 1,849 press releases posted in the last 24 hours and 444,974 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
EYLEA HD® (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image